Abstract
Background: Cecropin-B (Cec-B) is an Antimicrobial Peptide (AMP) found in insects.
Objectives: Recombinant production of Cec-B peptide in Escherichia coli (Rosetta™ DE3), and studying its anticancer effect on Hepatocellular Carcinoma Cell line (HCC).
Methods: The Cec-B gene of Drosophila melanogaster was synthesized by PCR assembly using the Simplified Gene Synthesis (SGS) method. To express the recombinant peptide in E. coli (Rosetta™ DE3); the synthesized gene was cloned into pET-15b expression vector. The recombinant peptide was expressed as insoluble aggregates called Inclusion Bodies (IBs) using 2mM lactose inducer. IBs were solubilized in a denatured form using 8 M urea followed by in-vitro protein refolding using rapid dilution method. The refolded Cec-B was purified using cation-exchange SP-FF column. Cytotoxicity of recombinant Cec-B (rCec-B) was reported on normal human lung cell line (WI-38), and Hepatocellular carcinoma cell line (HepG2).
Results: The Cec-B gene was expressed and purified at concentration 1.212±0.1 mg/ml which represents 48.49±4% of the total proteins injected to the column (2.5±0.2 mg/ml). The safe dose of purified rCec-B on normal WI-38 cells was calculated to be 1.57 mg/ml. The half-maximal Inhibitory Concentration (IC50) of rCec-B on HepG2 cell line was calculated to be 25 μg/ml. Scanning Electron Microscope (SEM) showed that untreated and treated HepG2 cells had cell diameters from 11-12.92 μm and 14.18-21.58 μm, respectively.
Conclusion: The results of this study revealed a successful expression of the rCec-B peptide using a pET-based expression system with a simple purification step. The purified peptide could be considered as a hopeful anticancer drug against HCC.
Keywords: Cecropin-B, recombinant expression, peptide, Escherichia coli, hepatocellular carcinoma, anticancer peptide.
Graphical Abstract
[http://dx.doi.org/10.1038/nrc3599] [PMID: 24060863]
[PMID: 24883085]
[http://dx.doi.org/10.3389/fphar.2018.01300] [PMID: 30483135]
[http://dx.doi.org/10.2174/1389201020666191011121722]
[http://dx.doi.org/10.1038/nri.2016.29] [PMID: 27087664]
[PMID: 30190664]
[http://dx.doi.org/10.2174/092986712801661004] [PMID: 22725698]
[http://dx.doi.org/10.1016/S0965-1748(99)00071-5] [PMID: 10560137]
[http://dx.doi.org/10.1186/1471-2490-8-5]
[http://dx.doi.org/10.1007/s430-001-8025-x] [PMID: 11388616]
[PMID: 7849420]
[http://dx.doi.org/10.1006/bbrc.1997.8014] [PMID: 9464264]
[http://dx.doi.org/10.1007/s12209-017-0068-8]
[http://dx.doi.org/10.3389/fbioe.2020.00162] [PMID: 32195241]
[http://dx.doi.org/10.1186/1475-2859-13-65] [PMID: 24885242]
[http://dx.doi.org/10.1128/AEM.71.9.5038-5043.2005] [PMID: 16151084]
[http://dx.doi.org/10.2174/138920111794295693] [PMID: 21050165]
[http://dx.doi.org/10.1016/j.genrep.2019.100571]
[http://dx.doi.org/10.1080/10826068.2017.1320291] [PMID: 28430025]
[http://dx.doi.org/10.1016/j.cbpb.2017.09.004]
[http://dx.doi.org/10.1007/978-1-4939-2205-5_15] [PMID: 25447870]
[http://dx.doi.org/10.1002/pro.465] [PMID: 20665695]
[http://dx.doi.org/10.2174/138920110791111979]
[http://dx.doi.org/10.1016/B978-0-12-420119-4.00008-2]
[http://dx.doi.org/10.3390/ijms19020626] [PMID: 29470444]
[http://dx.doi.org/10.1016/S2221-1691(12)60237-8] [PMID: 23569855]
[http://dx.doi.org/10.2147/OTT.S56115]
[http://dx.doi.org/10.5114/aoms.2015.53306] [PMID: 26322098]
[http://dx.doi.org/10.1155/2012/967347] [PMID: 23316341]
[http://dx.doi.org/10.1093/abbs/gmq021] [PMID: 20383464]
[http://dx.doi.org/10.1016/B978-0-323-42866-8.00004-6]
[http://dx.doi.org/10.2174/0929866525666181026160852] [PMID: 30370841]
[http://dx.doi.org/10.3748/wjg.v10.i12.1755] [PMID: 15188500]
[http://dx.doi.org/10.1016/B978-0-08-100623-8.00018-9]
[http://dx.doi.org/10.3390/proteomes5010004] [PMID: 28248255]
[http://dx.doi.org/10.1016/B978-0-08-100623-8.00022-0]
[http://dx.doi.org/10.1002/0471140864.ps0802s15] [PMID: 18429204]